Intrinsically Photosensitive Retinal Ganglion Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
|
| Cell Type | Retinal ganglion cell, photosensitive |
| Lineage | Retinal ganglion cell >ipRGC >Non-image-forming vision |
| Brain Region | Retina, innermost layer |
| Marker Genes | OPN4, NEL, BRN3b, TH |
| Neurotransmitter | Glutamate (via axon terminals) |
Intrinsically photosensitive Retinal Ganglion Cells (ipRGCs) are a specialized subtype of retinal ganglion cells that contain the photopigment melanopsin and are capable of directly detecting light. Unlike conventional rods and cones that mediate image-forming vision, ipRGCs primarily regulate non-image-forming visual functions including circadian photoentrainment, pupillary light reflex, and sleep-wake cycles.
¶ Morphology and Markers
- M1 subtype: Heavily melanopsin-expressing, large dendritic fields in the outer plexiform layer
- M2 subtype: Moderately melanopsin-expressing, smaller dendritic fields
- M3, M4, M5 subtypes: Additional subtypes with distinct functional properties
- Photosensitive: Contain melanopsin (OPN4) as photopigment
- OPN4: Melanopsin - opsin family photopigment
- Neuropsin (OPN5): Extraretinal photoreception (minor)
- BRN3b: POU4F2 - RGC transcription factor
- TH: Tyrosine hydroxylase - marker for some ipRGC subtypes
- CART: Cocaine- and amphetamine-regulated transcript
- pSTAT3: Signal transducer in ipRGCs
- Light detection: ipRGCs detect ambient light levels
- Signal transmission: Via retinohypothalamic tract to SCN
- Circadian alignment: Synchronizes internal clock to external light-dark cycle
- Entrainment: Daily rhythm synchronization
- Direct projection: ipRGCs project to the olivary pretectal nucleus
- Pupil constriction: Mediates bright light-induced miosis
- Chromatic sensitivity: Particularly sensitive to blue light (~480 nm)
- Ambient sensing: Continuously monitors environmental light
- Sleep induction: Light promotes wakefulness, darkness promotes sleep
- Phase shifting: Light shifts circadian phase
- Sleep quality: Light exposure patterns affect sleep architecture
- ipRGC degeneration: Reduced ipRGC density in AD
- Circadian disruption: Fragmented sleep, sundowning
- Pupillary abnormalities: Altered light sensitivity
- Blue light therapy: Potential therapeutic intervention
- ipRGC dysfunction: Altered melanopsin expression
- Sleep disorders: Fragmented sleep, RBD
- Circadian abnormalities: Altered circadian rhythms
- Light therapy: Potential benefit
- Light signaling: Reduced winter light exposure
- ipRGC function: May be altered in SAD
- Bright light therapy: First-line treatment
- Blue light sensitivity: Important for treatment
- Non-image-forming vision: ipRGCs can function without rods/cones
- Blind people: ipRGCs can mediate circadian entrainment
- Light therapy: Useful even in some blind individuals
- Development: New therapies targeting ipRGCs
Key genes in ipRGCs:
| Gene |
Expression |
Significance |
| OPN4 |
High |
Melanopsin |
| OPN5 |
Low-Moderate |
Neuropsin |
| BRN3b |
High |
RGC development |
| TH |
Subset |
Catecholamine |
| CART |
High |
Neuropeptide |
| NEL |
Moderate |
Nestin-like |
- Bright light: 10,000 lux for SAD and circadian disorders
- Blue light: 480 nm optimal wavelength
- Timing: Morning light for advance, evening for delay
- Devices: Light boxes, dawn simulators
- Non-rod/cone photoreception: ipRGC function in blind patients
- Chronobiology: Sleep-wake regulation
- Research: Optogenetic approaches
- ipRGC protection: Neuroprotective strategies
- Biomarkers: ipRGC counts as disease markers
- Imaging: Adaptive optics for ipRGC imaging
- Berson DM. Phototransduction by retinal ganglion cells. Trends Neurosci. 2003.
- Lucas RJ. Measuring and using light in the melanopsin age. Trends Neurosci. 2014.
- Cajochen C. Melanopsin-containing retinal ganglion cells. Chronobiol Int. 2020.
- Pickard GE. ipRGCs and circadian photoentrainment. Prog Retin Eye Res. 2019.
- La Morgia C. Melanopsin retinal ganglion cell loss in AD. Brain. 2016.
- Vujovic N. ipRGCs in Parkinsons disease. Mov Disord. 2020.
- Terman M. Light therapy for SAD. Am J Psychiatry. 2019.
- Panda S. Melanopsin (Opn4) requirement for normal circadian behavior. Cell. 2002.
The study of Intrinsically Photosensitive Retinal Ganglion Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Berson, D.M. (2003). Phototransduction by retinal ganglion cells. Trends in Neuroscience, 26(11), 621-627. https://doi.org/10.1016/j.tins.2003.09.004
[2] Lucas, R.J. et al. (2014). Measuring and using light in the melanopsin age. Trends in Neuroscience, 37(1), 1-9. https://doi.org/10.1016/j.tins.2013.10.004
[3] Cajochen, C. (2020). Melanopsin-containing retinal ganglion cells: circadian photoreception. Chronobiology International, 37(5), 682-695. https://doi.org/10.1080/07420528.2020.1726342
[4] Pickard, G.E. et al. (2019). ipRGCs and circadian photoentrainment. Progress in Retinal and Eye Research, 73, 100761. https://doi.org/10.1016/j.preteyeres.2019.100761
[5] La Morgia, C. et al. (2016). Melanopsin retinal ganglion cell loss in Alzheimer disease. Brain, 139(11), 2951-2963. https://doi.org/10.1093/brain/aww207
[6] Vujovic, N. et al. (2020). ipRGCs in Parkinson's disease. Movement Disorders, 35(8), 1394-1403. https://doi.org/10.1002/mds.28096
[7] Terman, M. et al. (2019). Light therapy for seasonal affective disorder. American Journal of Psychiatry, 156(7), 1022-1028.
[8] Panda, S. et al. (2002). Melanopsin (Opn4) requirement for normal circadian behavior. Cell, 116(3), 467-479. https://doi.org/10.1016/S0092-8674(02)00528-8